Announcements Trials

Browse Landscape

Status

Completed 2 Unknown 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Thyroid Nodule 3 Liver Neoplasms 3 Polycystic Ovary Syndrome 2 Hypersensitivity 2 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Thoracic Neoplasms 1 Salivary Gland Diseases 1 Rectal Neoplasms 1 Ovarian Neoplasms 1 Ovarian Cysts 1 Oligomenorrhea 1 Menstruation Disturbances 1 Malignant Tumor of Women's Reproductive System 1 Lung Neoplasms 1 Liver Cirrhosis 1 Leiomyoma 1 Intestinal Perforation 1 Hyperandrogenism 1 Hirsutism 1 Head and Neck Neoplasms 1 Enterocolitis, Necrotizing 1 Endometrial Neoplasms 1 Endocrine System Diseases 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma, Hepatocellular 1

Interventions

Paclitaxel 35 Carboplatin 35 Bevacizumab 14 olaparib 13 niraparib 11 apatinib 11 Gemcitabine 10 liposomal doxorubicin 9 Hyperthermic Intraperitoneal Chemotherapy 9 Cisplatin 9 pembrolizumab 8 Cyclophosphamide 8 fludarabine 7 Etoposide 7 Topotecan 6 fluzoparib 5 Surveys and Questionnaires 5 Drug Therapy 5 Albumin-Bound Paclitaxel 5 anlotinib 4 Immunohistochemistry 4 Ifosfamide 4 Doxorubicin 4 Docetaxel 4 Cytoreduction Surgical Procedures 4 Taxes 3 Surgical Procedures, Operative 3 Poly(ADP-ribose) Polymerase Inhibitors 3 Neoadjuvant Therapy 3 Laparoscopy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Ovarian Neoplasms × Ultrasonography × Clear all

NCT03808792 2019-01-18

ISAAC

Charles University, Czech Republic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡